Perioperative Hemodynamic Optimization in High-Risk Patients Using Less-Invasive Monitoring Methods
Multicenter Randomized Controled Trial of Perioperative Hemodynamic Optimization in High-Risk Patients Using Less-Invasive Monitoringng Methods
2 other identifiers
interventional
400
1 country
1
Brief Summary
The aim of this study is to evaluate different strategies of hemodynamic optimization in high risk surgical patients during the first twelve postoperative hours in ICU based on a protocol guided by a less invasive monitorig tool (Vigileo®), oriented by a fiberoptic central venous catheter that allows continuous monitorig of SvcO2 (PreSep®), and a pressure transducer (FloTrac®) that allows cardiac output calculation by the standard deviation of mean arterial pressure or a standard resuscitation strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2006
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 11, 2006
CompletedFirst Posted
Study publicly available on registry
September 12, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2007
CompletedSeptember 12, 2006
September 1, 2006
September 11, 2006
September 11, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
60 days mortality
Secondary Outcomes (3)
Organ dysfunction by means of SOFA score,
Postoperative complications, and
ICU and hospital lenghts of stay.
Interventions
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- High risk elective surgeries\* according to adapted Shoemaker criteria.
- Request of post-operative support by the surgeon and anesthetist.
- Patients that have need of central venous and arterial catheters according to surgeon, critical care physician or anesthetist evaluation.
- Informed consent will be obtained from all patients enrolled or their next of kin.
You may not qualify if:
- Patients with terminal disease, submitted to palliative surgery;
- Cardiac failure class IV of NYHA;
- Chronic renal failure without dyalisis and intolerant to fluids;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital do Servidor Público Estadual
São Paulo, São Paulo, 04039901, Brazil
Study Officials
- STUDY CHAIR
Ederlon Rezende, MD
Hospital do Servidor Publico Estadual
- PRINCIPAL INVESTIGATOR
Álvaro Réa-Neto, MD
Hospital de Clínicas da Universidade Federal do Paraná
- PRINCIPAL INVESTIGATOR
Ciro L Mendes, MD
Hospital Universitário da Universidade Federal da Paraíba
- PRINCIPAL INVESTIGATOR
Fernando S Dias, MD
Hospital São Lucas da Pontifice Universidade Católica do Rio Grande do Sul
- PRINCIPAL INVESTIGATOR
José Eduardo C Castro, MD
Hospital Copa D'Or
- PRINCIPAL INVESTIGATOR
Rubens C Costa Filho, MD
Hospital Procardíaco
- PRINCIPAL INVESTIGATOR
Suzana Margareth A Lobo, MD
Hospital de Base da Faculdade de Medicina de São José do Rio Preto
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 11, 2006
First Posted
September 12, 2006
Study Start
August 1, 2006
Study Completion
June 1, 2007
Last Updated
September 12, 2006
Record last verified: 2006-09